Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Active Not Recruiting NCT04461808

Tomosynthesis as Primary Test for Breast Cancer Screening

Conditions: Breast Cancer

Sex: Female
Ages: 45 Years – 65 Years
Healthy volunteers: Yes
Phase: NA
Enrollment: 10156
Sponsor: Azienda USL Reggio Emilia - IRCCS

Location: Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia Reggio Emilia Italy

Summary

Randomized trial comparing tomosynthesis plus synthetic 2D Mammography vs Digital Mammography in respect to incidence of advanced cancers (interval and following round) and interval cancers.

Eligibility Criteria

Inclusion Criteria: * Women scheduled for a new round of mammographic screening * resident in the province Exclusion Criteria: * previous breast cancer diagnosis * pregnancy or suspicion of pregnancy * presence of BRCA1/2 gene mutation * Previous Digital Breast Tomosynthesis performed * unable to understand informed consent * chemotherapy in progress * presence of breast implant

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT04461808). StuddyBuddy aggregates publicly available trial information.